Feasibility of Mask-Free Radiotherapy for Brain Tumor Patients
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Study ID
- NCT07323966
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Surface Guided Radiation Therapy without mask — DEVICEPatients are positioned using SGRT based on the reference position reconstructed from the simulation scanner. They are asked to remain still during the typical duration of a conventional radiotherapy session. Patient motion is monitored by SGRT throughout the simulated session. A CBCT scan is performed before and after the session. No treatment is delivered.
Study Details
The aim of this study is to investigate the technical feasibility of brain radiotherapy without immobilization masks using surface imaging to ensure accurate patient positioning and continuous motion monitoring.
Key Dates
- First listed
- Jan 7, 2026
- Start date
- Nov 18, 2025
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: Radiotherapy session without maskA radiotherapy session without a mask will be simulated twice (during the first week and last week of treatment) during two scheduled treatment sessions.
Primary Outcome Measure
Stability of patient's position [ Time Frame: Through the course of radiation therapy (up to 6 weeks) ]
Central Contacts
- Dario Di Perri+32 2 764 47 52
Find similar trials
Related Studies
- Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPHASE2 · Recruiting · Northwell Health · New York, New York
- Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed GlioblastomaPHASE1/PHASE2 · Recruiting · Northwell Health · New York, New York
- Study of Letrozole in Recurrent GliomasEARLY_PHASE1 · Recruiting · University of Cincinnati · Cincinnati, Ohio
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California